What Are Neuroprotective Peptides?
Neuroprotective peptides are a class of bioactive peptides that protect neurons from damage, degeneration, or death caused by ischemia, oxidative stress, excitotoxicity, neuroinflammation, or other insults. These peptides are of tremendous research interest due to their potential to modulate neurodegenerative processes and support neuronal survival and function.
Key Neuroprotective Peptides
Semax
An ACTH-derived heptapeptide that strongly upregulates BDNF and NGF — two key neurotrophic factors essential for neuronal survival, growth, and synaptic plasticity. Semax has shown robust neuroprotective effects in ischemic brain injury models. Read the full Semax guide.
BPC-157
While primarily studied for tissue repair, BPC-157 demonstrates significant neuroprotective properties through modulation of the dopaminergic, serotonergic, and GABAergic systems. Research has shown protective effects in models of traumatic brain injury, peripheral nerve damage, and neurotoxicity. Read the full BPC-157 guide.
GHK-Cu
The copper peptide modulates the expression of genes involved in neuronal survival, axonal growth, and antioxidant defense. Its gene-reprogramming effects include upregulation of neuroprotective pathways and downregulation of neuroinflammatory mediators.
TB-500
Thymosin Beta-4 has shown neuroprotective effects through promotion of oligodendrocyte differentiation (essential for myelination), reduction of neuroinflammation, and support of axonal regrowth in injury models.
Mechanisms of Neuroprotection
| Mechanism | Peptides Involved |
|---|---|
| Neurotrophic factor upregulation (BDNF, NGF) | Semax, GHK-Cu |
| Anti-neuroinflammation | BPC-157, TB-500, GHK-Cu |
| Antioxidant defense | GHK-Cu, Semax |
| Dopaminergic system support | BPC-157, Semax |
| Myelination support | TB-500 |
| Blood-brain barrier protection | BPC-157 |
Research Applications
- Ischemic injury: Semax has the most data for stroke/ischemia models
- Traumatic brain injury: BPC-157 and TB-500 for post-TBI recovery
- Neurodegenerative disease models: GHK-Cu for gene-expression-based approaches
- Peripheral neuropathy: BPC-157 for nerve regeneration
- Cognitive decline: Semax for age-related cognitive changes
Conclusion
Neuroprotective peptides offer researchers diverse tools for studying neuronal survival and recovery. From Semax’s direct neurotrophic factor modulation to GHK-Cu’s broad gene reprogramming, these peptides target multiple neuroprotective pathways and provide valuable approaches to understanding and potentially modulating neurodegenerative processes.
All products are sold strictly for research purposes only. Not for human consumption.